Notes
The study was supported by Pfizer Denmark.
Reference
Gustafsson N, et al. Societal costs due to meningococcal disease: a national registry-based study. ClinicoEconomics and Outcomes Research : 2 Oct 2018. Available from: URL: https://doi.org/10.2147/CEOR.S175835
Rights and permissions
About this article
Cite this article
Meningococcal disease substantial cost burden in Denmark. PharmacoEcon Outcomes News 814, 15 (2018). https://doi.org/10.1007/s40274-018-5358-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-018-5358-4